{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:23:15Z","timestamp":1783009395017,"version":"3.54.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"crossref","award":["UL1 TR 000002"],"award-info":[{"award-number":["UL1 TR 000002"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["KL2 TR 000134"],"award-info":[{"award-number":["KL2 TR 000134"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.nmd.2013.01.012","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T04:18:02Z","timestamp":1362111482000},"page":"316-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Oculopharyngeal muscular dystrophy as a cause of progression of weakness in antibody positive myasthenia gravis"],"prefix":"10.1016","volume":"23","author":[{"given":"Bj\u00f6rn","family":"Oskarsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Ringel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2013.01.012_b0005","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","article-title":"Treatment of autoimmune myasthenia gravis","volume":"61","author":"Richman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2013.01.012_b0010","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/jnnp.56.6.702","article-title":"Acute myopathy associated with large parenteral dose of corticosteroid in myasthenia gravis","volume":"56","author":"Panegyres","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2013.01.012_b0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/17482968.2012.711836","article-title":"Unusual occurrence of amyotrophic lateral sclerosis in myasthenia gravis","volume":"13","author":"Naik","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.nmd.2013.01.012_b0020","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10067-006-0459-z","article-title":"A case of polymyositis complicated with myasthenic crisis","volume":"26","author":"Yoshidome","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.nmd.2013.01.012_b0025","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10072-011-0579-3","article-title":"Temporal coincidence of myasthenia gravis and Guillain Barre syndrome associated with Hashimoto thyroiditis","volume":"32","author":"Wang","year":"2011","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nmd.2013.01.012_b0030","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.286.19.2437","article-title":"Oculopharyngeal muscular dystrophy in Hispanic New Mexicans","volume":"286","author":"Becher","year":"2001","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.nmd.2013.01.012_b0035","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0960-8966(97)00077-1","article-title":"Recent studies on oculopharyngeal muscular dystrophy in Quebec","volume":"7","author":"Bouchard","year":"1997","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2013.01.012_b0040","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archneur.59.3.474","article-title":"Unequal crossing-over in unique PABP2 mutations in Japanese patients: a possible cause of oculopharyngeal muscular dystrophy","volume":"59","author":"Nakamoto","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2013.01.012_b0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.nmd.2011.06.751","article-title":"Acetylcholine receptor antibodies in patients with genetic myopathies: clinical and biological significance","volume":"22","author":"Lane","year":"2012","journal-title":"Neuromuscul Disord"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613000382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613000382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:01:15Z","timestamp":1760774475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896613000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0960896613000382"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2013.01.012","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oculopharyngeal muscular dystrophy as a cause of progression of weakness in antibody positive myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2013.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}